Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Pallidal Deep Brain Stimulation in Dystonia: Investigating Differential Response by Dystonia Distribution.

Tremor and other hyperkinetic movements (New York, N.Y.)·2026
Same author

Behavioral signature of trihexyphenidyl in the <i>TOR1A</i> (DYT1) knockin mouse model of dystonia.

Dystonia (Lausanne, Switzerland)·2026
Same author

Changes in Purine Metabolism During Differentiation of Dopamine Neurons from Human Induced Pluripotent Stem Cells.

Cellular and molecular neurobiology·2026
Same author

Treatment of Blepharospasm with Methylphenidate: A Telemedicine Study.

Movement disorders clinical practice·2025
Same author

Modeling rare genetic disease with gene-edited induced pluripotent stem cells: relevance of the starting stock line.

Stem cells translational medicine·2025
Same author

'What's in a Name?' Naming Genetically Determined Movement Disorders: Gap and Controversy.

Movement disorders : official journal of the Movement Disorder Society·2025
Same journal

Key Considerations in Telestroke Program Management.

Continuum (Minneapolis, Minn.)·2026
Same journal

Neurology's Action Potential: Delivering on the Promise of Brain Health.

Continuum (Minneapolis, Minn.)·2026
Same journal

Erratum.

Continuum (Minneapolis, Minn.)·2026
Same journal

Management of Large Artery Atherosclerosis.

Continuum (Minneapolis, Minn.)·2026
Same journal

Thrombolysis, Thrombectomy, and Antithrombotic Therapy for Acute Ischemic Stroke.

Continuum (Minneapolis, Minn.)·2026
Same journal

Stroke in Children and Younger Adults.

Continuum (Minneapolis, Minn.)·2026
See all related articles

Related Experiment Video

Updated: Jan 21, 2026

Measurement & Analysis of the Temporal Discrimination Threshold Applied to Cervical Dystonia
10:05

Measurement & Analysis of the Temporal Discrimination Threshold Applied to Cervical Dystonia

Published on: January 27, 2018

10.2K

The Dystonias.

H A Jinnah

    Continuum (Minneapolis, Minn.)
    |July 30, 2019
    PubMed
    Summary
    This summary is machine-generated.

    Dystonia diagnosis and classification have advanced significantly, with new genetic discoveries and broader sequencing approaches improving inherited dystonia identification. Treatment remains symptomatic but etiology determination is key for emerging therapies.

    More Related Videos

    Implantation of Osmotic Pumps and Induction of Stress to Establish a Symptomatic, Pharmacological Mouse Model for DYT/PARK-ATP1A3 Dystonia
    10:41

    Implantation of Osmotic Pumps and Induction of Stress to Establish a Symptomatic, Pharmacological Mouse Model for DYT/PARK-ATP1A3 Dystonia

    Published on: September 12, 2020

    7.9K
    Low-cost Protocol of Footprint Analysis and Hanging Box Test for Mice Applied the Chronic Restraint Stress
    06:38

    Low-cost Protocol of Footprint Analysis and Hanging Box Test for Mice Applied the Chronic Restraint Stress

    Published on: January 23, 2019

    20.1K

    Related Experiment Videos

    Last Updated: Jan 21, 2026

    Measurement & Analysis of the Temporal Discrimination Threshold Applied to Cervical Dystonia
    10:05

    Measurement & Analysis of the Temporal Discrimination Threshold Applied to Cervical Dystonia

    Published on: January 27, 2018

    10.2K
    Implantation of Osmotic Pumps and Induction of Stress to Establish a Symptomatic, Pharmacological Mouse Model for DYT/PARK-ATP1A3 Dystonia
    10:41

    Implantation of Osmotic Pumps and Induction of Stress to Establish a Symptomatic, Pharmacological Mouse Model for DYT/PARK-ATP1A3 Dystonia

    Published on: September 12, 2020

    7.9K
    Low-cost Protocol of Footprint Analysis and Hanging Box Test for Mice Applied the Chronic Restraint Stress
    06:38

    Low-cost Protocol of Footprint Analysis and Hanging Box Test for Mice Applied the Chronic Restraint Stress

    Published on: January 23, 2019

    20.1K

    Area of Science:

    • Neurology
    • Genetics
    • Medical Diagnostics

    Background:

    • Dystonia encompasses diverse disorders with varied clinical presentations.
    • Accurate diagnosis relies on recognizing characteristic clinical features.
    • Etiology determination is increasingly vital due to evolving diagnostic and therapeutic landscapes.

    Observation:

    • A broadly accepted classification system for dystonia subtypes has emerged in the last five years.
    • Recent genetic discoveries have significantly advanced the understanding of dystonia's biological processes.
    • Diagnostic strategies for inherited dystonias are shifting towards comprehensive genetic testing.

    Findings:

    • New classification aids in clinical recognition and diagnosis of dystonia subtypes.
    • Advances in gene discovery and biological understanding are transforming inherited dystonia diagnosis.
    • Genetic testing is moving towards large gene panels and whole exome sequencing.

    Implications:

    • Determining the etiology of dystonia is crucial due to the growing number of identified disorders.
    • Emerging specific and disease-modifying therapies necessitate precise etiological diagnosis.
    • The evolving diagnostic landscape promises more targeted and potentially disease-modifying treatments for dystonia patients.